Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coriomycin tablets for carbapenem‑resistant infections in patients with solid tumors
ChiCTR2100050254Phase 4Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of colistimethate sodium in Nonhematologic neoplasms and bacterial disease (4 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Leukocyte count, C-reactive protein and 1 more. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
colistimethate sodium
03
Conditions
Nonhematologic neoplasmsbacterial disease
Beyond the preview
Go deeper on ChiCTR2100050254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050254.